4//SEC Filing
Patel Sunil 4
Accession 0000899243-22-035039
CIK 0000886163other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 9:06 PM ET
Size
7.2 KB
Accession
0000899243-22-035039
Insider Transaction Report
Form 4
Patel Sunil
Director
Transactions
- Disposition to Issuer
Common Stock
2022-11-01−1,004→ 28,820 total - Disposition to Issuer
Employee Stock Option (right to buy)
2022-11-01−4,340→ 0 totalExercise: $90.68Exp: 2032-06-10→ Common Stock (4,340 underlying)
Footnotes (2)
- [F1]Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.
- [F2]The stock option vests and is exercisable on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders following the grant date or (ii) on June 10, 2023.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001503062
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 9:06 PM ET
- Size
- 7.2 KB